No description available.

No abstract available. / Thesis (M.D.)-University of KwaZulu-Natal, 2004.

Group I introns are catalytic RNAs capable of self-splicing out of RNA transcripts. Ribozymes derived from these group I introns are used to explore the molecular recognition properties involved in intron catalysis. New ribozyme reactions are designed based on the inherent ability of these ribozymes to perform site-specific nucleophilic attacks. This study explores the molecular recognition properties of group I intron-derived ribozyme reactions and describe a new ribozyme reaction involving molecular recognition properties previously not seen.We report the development, analysis, and use of a new combinatorial approach to analyze the substrate sequence dependence of suicide inhibition, cyclization, and reverse cyclization reactions catalyzed by a group I intron from the opportunistic pathogen Pneumocystis carinii. We demonstrate that the sequence specificity of these Internal Guide Sequence (IGS) mediated reactions is not high, suggesting that RNA targeting strategies which exploit tertiary interactions could have low specificity due to the tolerance of mismatched base pairs.A group I intron-derived ribozyme from P. carinii has been previously shown to bind an exogenous RNA substrate, splice-out an internal segment, and then ligate the two ends back together (the trans excision-splicing reaction). We now report that a group I intron derived ribozyme from the ciliate Tetrahymena thermophila can also perform the trans excision-splicing reaction, although not nearly as well as the P. carinii ribozyme.In addition, we discovered a new ribozyme reaction called trans insertion-splicing where the P. carinii ribozyme binds two exogenous RNA substrates and inserts one directly into the other. Although this reaction gives the reverse products of the trans excision-splicing reaction, the trans insertion-splicing reaction is not simply the reverse reaction. The ribozyme recognizes two exogenous substrates through more complex molecular recognition interactions than what has been previously seen in group I intron-derived ribozyme reactions. We give evidence for this new reaction mechanism composed of three steps, with intermediates attached to the ribozyme.

Pneumocystis species are opportunistic fungal pathogens that cause severe pneumonia in immunocompromised hosts, including AIDS patients. Pneumocystis species have a biphasic life cycle consisting of single-nucleated trophic forms and ascus-like cysts. Both stages live within the host, and, thus, must contend with threats from the host immune system. The cyst cell wall β-glucans have been shown to stimulate immune responses in lung epithelial cells, dendritic cells and alveolar macrophages. Little is known about how the trophic life forms, which do not have a fungal cell wall, interact with immune cells. In this study, the immune response to the life cycle stages of Pneumocystis murina was evaluated. Here, we report differences in the immune response of immunocompetent mice to the trophic and cystic life cycle stages of P. murina. Upon infection with purified trophic forms, wild-type adult mice developed a delayed innate and adaptive immune response compared to inoculation with the normal mixture of trophic forms and cysts. Cysts, but not trophic forms, stimulated Th1-type responses in the lungs of infected mice. Surprisingly, trophic forms are sufficient to generate protective adaptive responses, leading to clearance in immunocompetent mice. We report that CD4+ T cells primed in the presence of trophic forms are sufficient to mediate clearance of trophic forms and cysts. In addition, primary infection with trophic forms is sufficient to prime B cell memory responses capable of clearing a secondary infection with Pneumocystis following CD4+ T cell depletion. While trophic forms are sufficient for initiation of adaptive immune responses in immunocompetent mice, infection of immunocompromised RAG2-/- mice with trophic forms in the absence of cysts does not lead to the severe weight loss and infiltration of innate immune cells associated with the development of Pneumocystis pneumonia. Dendritic cells screen the alveolar spaces for pathogens, and are in a prime position to initiate the immune response against lung pathogens, including Pneumocystis. Our data demonstrate that trophic forms broadly dampen the ability of dendritic cells to respond to pathogen-associated molecular patterns. Bone marrow-derived dendritic cells were stimulated with trophic forms, a mixture of trophic forms and cysts, and various other inflammatory materials, including β-glucan. Trophic forms inhibited multiple components involved in antigen presentation by dendritic cells, including secretion of inflammatory cytokines and expression of MHC class II and costimulatory molecules on the cell surface. Furthermore, trophic forms suppressed or failed to induce the expression of multiple genes related to activation and maturation in dendritic cells. Dendritic cells silenced by trophic forms are unable to induce CD4+ T cell responses. These data suggest that immune evasion by trophic forms is dependent on the suppression of innate responses, and the development of adaptive immunity represents a “point of no return” at which the trophic forms are no longer able to escape clearance.

Dapsone has been shown to be an effective agent against Pneumocystis carinii pneumonia, an opportunistic infection in AIDS patients. Oral administration of dapsone is associated with several adverse effects, including methemoglobinemia, hemolytic anemia and photosensitivity reactions. To reduce the adverse effects associated with oral dapsone, an alternative would be to administer the prodrug diacetyldapsone (DADDS) into the lung, which may be hydrolyzed to monoacetyldapsone and the active metabolite dapsone. The purpose of this investigation was to determine the effect of cyclodextrindiacetyldapsone (CD-DADDS) complex upon the cultured lung cells and whether or not cultured lung cells could activate DADDS into dapsone, the active metabolite. The effect of the CD-DADDS complex upon the growth of cultured CRL 7272 lung cells was assessed by the trypan blue dye exclusion technique. There was no significant reduction in cell number as compared to the control for incubations with three different concentrations of CD-DADDS complex. The amount of arylamine produced by hydrolysis was initially monitored by the Bratton-Marshall diazotization technique. Only incubation with 0.01% DADDS in 1% CD showed a significant time dependent hydrolysis of DADDS over a period of 72 hours due to insensitivity of the assay method. Over the same period, cultured lung cells produced 1.65 μmoles of metabolite/106 cells. However interfering substances could contribute to this value. To provide additional evidence for hydrolysis and to quantitatively estimate the amount of dapsone, a more sensitive HPLC method was used. The results obtained from HPLC analysis demonstrated a significant concentration and time dependent increase in the amount of dapsone with 0.001% DADDS, 0.005% DADDS and 0.01% DADDS incubations, respectively. Over a period of 48 hours, 255ng of dapsone/ 106 cells was formed in an incubation containing 0.01% DADDS.

Le genre Pneumocystis désigne un groupe de champignons opportunistes présentant une étroite spécificité d'hôte. Il détermine lors d'immunodépression sévère une infection pulmonaire grave, la pneumonie à Pneumocystis (PPC). La transmission de Pneumocystis par voie aérienne d'un hôte développant une PPC à un hôte susceptible a été démontrée à l'aide des modèles murins. Les travaux menés chez la souris ont montré également que des sujets immunocompétents colonisés par Pneumocystis murina peuvent transmettre le champignon à des souris immunodéprimées qui développeront une PPC ultérieurement. Les individus colonisés par Pneumocystis sp., ainsi que ceux développant une PPC, participeraient au réservoir du champignon. La survenue de cas groupés de PPC en milieu hospitalier est en faveur de la transmission interindividuelle de Pneumocystis jirovecii (P.jirovecii) chez l’homme. La détection de l'ADN de P.jirovecii dans l'air exhalé par les patients développant une PPC suggère que cette transmission se fait par voie aérienne. La caractérisation des populations infectées par P.jirovecii et la caractérisation génotypique du champignon au sein de son réservoir humain constituent la base de ce travail de recherche. Nous avons montré que la prévalence de la colonisation par P.jirovecii est faible chez les patients atteints de mucoviscidose et suivis dans notre CHU. La participation de ces patients au réservoir de P.jirovecii à Brest serait donc marginale. Cette faible prévalence pourrait être le reflet d'une faible circulation du champignon dans les communautés humaines dans notre région. Nous avons évalué le dosage du ß-1,3-D glucane sérique pour dépister les populations infectées. Ce dosage couplé à la détection de P.jirovecii dans les prélèvements respiratoires par la microscopie et la PCR, permet de différencier les patients développant une PPC et les patients présentant une colonisation pulmonaire par P.jirovecii. De plus, les premières données sur le ß-1,3-D glucane au cours de la primo-infection chez le nourrisson ont été obtenues.En termes de caractérisation de P.jirovecii dans notre région, l'analyse du locus dihydropteroate synthase (DHPS) a montré que: i) le lieu habituel de résidence plutôt que le lieu de diagnostic de l’infection à P.jirovecii serait un facteur prédictif d’infection par un mutant, ii) P.jirovecii pourrait circuler en France d’une région à une autre via des voyageurs infectés, iii) la prévalence de mutants potentiellement résistants chez les patients vivant effectivement à Brest était de 0%. L'analyse des séquences des "internal transcribed spacers" (ITS) 1 et 2 de P. jirovecii conforte l'hypothèse que les patients développant une PPC et les patients colonisés sont infectés par des populations fongiques présentant des caractéristiques identiques. Tous les patients, quelle que soit la présentation clinique de leur infection, constitueraient un réservoir unique et commun de P.jirovecii. Les travaux de génotypage ont constitué l'étape préalable nécessaire à l'analyse de cas groupés d'infections à P.jirovecii survenus chez des patients transplantés rénaux au CHU de Brest. Nous avons apporté des données originales sur le rôle des patients colonisés en tant que source potentielle de P. jirovecii dans un contexte d'acquisition et de transmission nosocomiales du champignon. Par ailleurs, la concordance partielle ou complète des génotypes ITS et DHPS dans les couples "prélèvements d'air–LBA" réalisés chez des patients développant une PPC est compatible avec l’exhalation du champignon et sa diffusion aérienne dans l’environnement hospitalier. Ces données apportent des arguments pour l'application de mesures de prévention des infections nosocomiales à P. jirovecii. Les précautions "gouttelettes" recommandées par la Société Française d'Hygiène Hospitalière devraient être appliquées a minima aux patients développant une PPC. Nous proposons leur extension aux patients colonisés par le champignon. / The genus Pneumocystis represents a group of opportunistic fungi that show strong host specificity. It is the cause of severe pneumonia (Pneumocystis Pneumonia [PCP]) in immunocompromised subjects. Pneumocystis transmission from a host with PCP to another susceptible host via the airborne route has been demonstrated in rodent models. Moreover, it has been established that Pneumocystis murina can be transmitted from immunocompetent mice, transiently colonized by the fungus, to immunocompromised susceptible mice that subsequently develop PCP. Colonized subjects and those developing PCP may be part of the fungus reservoir. Reports of PCP case cluster in hospital strongly suggest that Pneumocystis jirovecii (P.jirovecii) transmission in humans may also occur. P.jirovecii DNA detection in the air surrounding PCP patients is consistent with the transmission of P.jirovecii via the airborne route.Our goals were to characterize human populations infected with P.jirovecii and to characterize P.jirovecii within its human reservoir. We showed that P.jirovecii was rarely involved in pulmonary colonization in patients with cystic fibrosis monitored in the Brest Hospital. Thus this patient population was not part of the human reservoir of the fungus in our region (Brittany, Western France). This low prevalence of colonization may reflect a low level of P.jirovecii circulation within human communities in Brittany. In order to improve the identification of patients infected with P.jirovecii, we evaluated ß-1,3-D glucan detection in serum samples. We showed that serum ß-1,3-D glucan levels combined with P.jirovecii detection in pulmonary samples using microscopic examination and a PCR assay make it possible to distinguish between PCP and pulmonary colonization. Moreover the first data on ß-1,3-D glucan levels during primary infection were obtained.In order to characterize P.jirovecii in our region, we performed the typing of P.jirovecii isolates from infected patients monitored at Brest hospital, using the dihydropteroate synthase (DHPS) and the internal transcribed spacer (ITS) 1 and 2 locus analysis. DHPS typing showed that i) the usual city of patient residence rather that the city in which the diagnosis of P.jirovecii infection has been made is a predictor of mutants, ii) mutants can be imported from one region to another through infected visitors, iii) the prevalence of mutants potentially resistant to sulfonamides was 0% in patients who effectively lived in the Brest geographic area. Results of ITS analysis in PCP patients and colonized patients are consistent with the hypothesis that these 2 patient groups are infected with similar P.jirovecii populations. All infected patients, whatever their clinical presentation, may be part of a common and unique reservoir of the fungus. We investigated an outbreak of P.jirovecii infections in 18 renal transplant recipients using the same typing method combined with patient encounter analysis. The results provided evidence of the role of colonized patients as potential sources of P.jirovecii. The same typing method was applied to pairs of pulmonary samples and room air samples of PCP patients. Full or partial matches of P.jirovecii types in pulmonary and air sample pairs were observed. These results are consistent with P.jirovecii exhalation by PCP patients in their close environment. These data support arguments for applying droplet precautions, at least to PCP patients, to prevent P.jirovecii transmission, as recommended by the "Société française d'hygiène hospitalière". We suggest extending droplet precautions to colonized patients to achieve the prevention of P.jirovecii nosocomial infections.

Depuis la disponibilité des combinaisons antirétrovirales (cART) en 1996, l’incidence des infections opportunistes classantes SIDA (IO), dont la pneumocystose (PCP) a très fortement diminué. Malgré tout, chez les patients infectés par le VIH, la PCP était la 2ème IO la + fréquente en France en 2001-2003 et les infections fongiques, avec 1 million de nouveaux cas/an de cryptococcose, restent un problème de santé publique majeur au niveau mondial. Cependant, depuis l’ère des cART, très peu de recherches épidémiologiques sur les infections fongiques dans les pays industrialisés ont été entreprises. C’est dans ce contexte que nous avons mené une étude épidémiologique de 2 infections fongiques chez les patients infectés par le VIH en France sur la French Hospital Database on HIV ANRS CO4 (FHDH) : la pneumocystose et l’aspergillose invasive. Concernant la pneumocystose, sur la période 2004-2011, dans la base FHDH, la moitié des 1259 cas de PCP étaient survenus chez des patients qui avaient interrompus leur suivi, et, pour ceux qui avaient déjà eu une IO avant la PCP, leur mortalité était de 25% à 3 ans. Pour l’aspergillose invasive (AI), après un retour national aux dossiers des cas déclarés sur 20 ans sur la base FHDH, un comité d’experts a validé 242 cas d’AI. Les données montrent que, chez les patients infectés par le VIH, seulement la moitié des AI validées répondaient aux critères EORTC. La mortalité à 3 mois après une AI s’est améliorée après l’ère des cART et un rôle protecteur du voriconazole sur la survie à 3 mois a également été démontré pour la 1ère fois chez les patients infectés par le VIH. / The advent of combined antiretroviral therapy (cART) in 1996 resulted in a dramatic fall in the incidence of AIDS-defining illness (ADI), including Pneumocystis jirovecii pneumonia (PCP). Nevertheless, PCP was the second most frequent ADI in France in 2001-2003 and fungal infections remain a major threat for HIV-infected individuals worldwide. Epidemiological data on fungal infections in the late cART period in resource-rich settings are scarce. The purpose of our work was to study changes in the epidemiology of fungal infections among HIV-infected individuals in France in the late cART period, focusing on PCP and invasive aspergillosis (IA) in the French Hospital Database on HIV ANRS CO4 (FHDH). In the FHDH, during the 2004-2011 period, half of the 1259 PCP cases occurred among HIV-infected individuals who had waning adherence to care, and for those who had a prior ADI before PCP the 3-year mortality rate was 25%. For the second study on IA, a review committee validated IA cases among all the cases that included a diagnostic code for aspergillosis (ICD-9 or ICD-10) in the FHDH over a 20-year period. Our study demonstrated that only half of validated IA cases among HIV-infected individuals met EORTC criteria. The 3-months survival rate after IA diagnosis improved after the advent of cART and a protective role of voriconazole was observed in the period after 2001.

Philosophiae Doctor - PhD / In the decade since first identified, the Acquired Immunodeficiency syndrome (AIDS) has become a serious global disease. The nature of the Human Immunodeficiency Virus (HIV) that causes AIDS, whereby a carrier may be asymptomatic yet remain infectious, has enabled its dramatic spread. The number of AIDS cases is increasing exponentially, averaging a doubling time of between 8-15 months in different countries. Of the millions of HIV carriers, it is now estimated that all will eventually go on to develop full-blown AIDS and probably die within 15 years. Unlike other infectiqus diseases, there is currently no known vaccine or cure. Further, HIV is now virtually completely dependent on volitional sexual behaviours for transmission to occur. It is therefore an entirely preventable disease. However, since the behaviours that contribute to HIV-transmission are influenced by biological, psychological, and social factors, their alteration in line with safer sexual practices has been shown to be considerably complex and difficult. Intervention strategies that have relied on imparting knowledge about the disease have achieved limited success in influencing behaviour change. Unsafe sexual practices, and the risk of HIV-infection, often continue even when knowledge regarding prevention is adequate. It has therefore become apparent that other variables intrude which may mediate between knowledge acquisition, attitude formation, and consequent sexual behaviours. There appear to be no models which adequately explain the complexities in this area, and which enable adequate intervention strategies to be developed. The present study was undertaken to redress this problem, and to explore those variables that mediate in the area. Various psychological and social factors appear to be implicated in influencing sexual attitudes and behaviours. In order to adequately test the impact of psychosocial variables that were found to have significant associations in an exploratory study, a measuring instrument was developed. The AIDS Psychosocial Scale was statistically validated using content, frequency, factor, and reliability analyses and included psychological factors of self concept, defenses of denial, repression, and rationalisation, perceived empowerment in the form of locus of control and selfefficacy, and the social factor of peer pressure susceptibility. The impact of these psychosocial variables on indices of knowledge, condom attitude, and sexual practices, and on other epidemiological variables was tested using a sample of students at the University of the Western Cape (n=308). Results indicated a number of correlational and causal links between variables, confirming the mediational role psychosocial factors have in influencing knowledge acquisition, attitude formation, and behaviour outcome. A profile of lower self concept, higher defenses, lower self-efficacy, more external locus of control, and higher peer pressure susceptibility emerged which was associated with poorer knowledge, more negative attitudes, and higher unsafe sex. Based on this study, a model of psychosocial mediation is developed and its implications for intervention strategies discussed.

The overall aim of this thesis is to improve knowledge about the prevention of infectious and bleeding complications in patients with hematological malignancies, primarily in those with chronic lymphocytic leukemia (CLL) and myelodysplatic syndrome (MDS). Hypogammaglobulinemia, impaired production of immunoglobulins (Ig), is an established risk factor for infection, but the impact of IgG pure subclass deficiency (IgG subclass deficiency with adequate production of IgG, IgA, and IgM) has been debated. In a retrospective single institution study, we concluded that pure IgG subclass deficiency in CLL patients is rare and is not associated with an increased risk of infection. Hence, routine analysis of IgG subclasses in patients with CLL is not warranted. There is no consensus on recommending vaccination against Streptococcus pneumoniae to CLL patients mainly because comparative studies are lacking. In our randomized trial, the efficacy of a conjugated pneumococcal vaccine on immune response was superior or equal to a polysaccharide vaccine for all pneumococcal serotypes common for the two vaccines. A conjugate pneumococcal vaccine should therefore be included in vaccination programs for patients with CLL. Bronchoalveolar lavage (BAL) is a well-established invasive method to identify the cause of pulmonary infiltrates in immunocompromised patients. In a retrospective trial, we have studied the diagnostic yield of BAL in patients with hematological malignancies. We concluded that BAL is highly useful in either verifying or excluding some of the important respiratory tract infections affecting these patients, particularly invasive pulmonary aspergillosis (IPA) and Pneumocystis jirovecii pneumonia (PJP). However, standardized procedures for BAL sampling should be continually revised to avoid unnecessary microbiological tests. Thrombocytopenia, an adverse prognostic factor in patients with MDS, can be aggravated by azacitidine, first-line treatment for high-risk MDS. Eltrombopag, a thrombopoietin-receptor agonist (TPO-R), alleviates thrombocytopenia in patients with immune thrombocytopenic purpura (ITP). In a phase I clinical trial, we concluded that the combination of eltrombopag and azacitidine in high-risk MDS patients with thrombocytopenia is feasible and well tolerated in doses up to 200 mg eltrombopag daily.

[ES] La presente tesis doctoral titulada "New nanostructured suports with signal amplification features for the detection of molecules and biomolecules of interest" se centra en el diseño y preparación de nuevos materiales híbridos orgánicos-inorgánicos constituidos por puertas moleculares soportadas sobre alúmina mesoporosa con el objetivo de desarrollar nuevos sistemas sensores con aplicaciones potenciales en el campo de la diagnosis y del control alimentario. En el primer capítulo de la tesis se introducen los conceptos en los que están basados los estudios realizados y los materiales preparados. A continuación, en el segundo capítulo se describen los objetivos generales de la tesis que serán abordados en los siguientes apartados. En el tercer capítulo se presenta el diseño y optimización de un nanodispositivo para la detección de la bacteria Mycoplasma fermentans. En primer lugar, los poros de una placa de alúmina mesoporosa se cargan con un indicador fluorescente (rodamina B). Seguidamente, la superficie es funcionalizada con una secuencia de ADN complementaria a una región altamente conservada de la subunidad ribosomal 16S de la bacteria Mycoplasma fermentans. El impedimento estérico generado por las secuencias de ADN ancladas al exterior de los poros impide la salida del indicador encapsulado. Únicamente en presencia de DNA de la bacteria Mycoplasma fermentans, se produce la apertura de los poros permitiéndose la difusión de la carga (rodamina B) que es posteriormente medida mediante espectroscopía de fluorescencia. En el capítulo cuatro se diseña de un nanodispositivo capaz de detectar de forma rápida, sensible y selectiva la bacteria Staphylococcus aureus. Para la preparación del material sensor, un soporte de alúmina mesoporosa es, en primer lugar, cargado con el indicador fluorescente rodamina B. A continuación, los poros del soporte son tapados mediante el anclaje de un aptámero que reconoce de forma específica la bacteria. Solamente en presencia de Staphylococcus aureus se produce la liberación del indicador encapsulado, que es posteriormente medido mediante espectroscopía de fluorescencia. Además, la respuesta obtenida es específica para Staphylococcus aureus. Este sistema ha sido ensayado en muestras reales. En el sexto capítulo, diseña un nanodispositivo híbrido orgánico-inorgánico consistente en un material de alúmina mesoporosa cubierto con una secuencia de ADN específica para la detección de ADN del hongo Pneumocystis jirovecii. En este caso, el soporte de alúmina cargado con rodamina B se recubre con una secuencia de ADN específica para el reconocimiento de este hongo. En presencia del organismo, la horquilla hibrida con el ADN del hongo, lo que resulta en una conformación triplex con elevada afinidad y estabilidad que induce, al mismo tiempo, el desplazamiento de este complejo de la superficie. Como consecuencia de este reconocimiento la carga se libera y es cuantificada mediante espectroscopía de fluorescencia. El sistema ha sido satisfactoriamente validado. En el séptimo capítulo, se diseña un sistema sensor con la capacidad de detectar gluten de forma rápida y sencilla en extractos de alimentos procesados y no procesados. Para ello, un soporte de alúmina mesoporosa se carga con rodamina B y los poros se recubren con un aptámero específicamente diseñado para la detección de la proteína gliadina, que constituye el 50 % del total del clúster de elementos que forman el gluten. La elevada afinidad y especificidad entre el aptámero y la proteína en cuestión hacen que en presencia de ésta se produzca un desplazamiento de la puerta molecular que permite la difusión del colorante encapsulado que es finalmente monitorizado mediante espectroscopía de fluorescencia. Finalmente, en el capítulo octavo se discuten de forma conjunta los resultados obtenidos en los capítulos anteriores y la potencial aplicación de los sistemas desarrollados en el actual sistem / [CA] La present tesi doctoral, titulada "New nanostructured supports with signal amplification features for the detection of molecules and biomolecules of interest", es centra en el disseny i preparació de nous materials híbrids orgànics-inorgànics constituïts per portes moleculars suportades sobre alúmina mesoporosa amb l'objectiu de desenvolupar nous sistemes sensors amb potencials aplicacions en el camp de la diagnosi i del control alimentari. En el primer capítol de la tesi s'introdueixen els conceptes en què estan basats els estudis realitzats i els materials preparats. A continuació, en el segon capítol es descriuen els objectius generals de la tesi que seran abordats en els següents apartats. En el tercer capítol es presenta el disseny i optimització d'un nanodispositiu per a la detecció de la bactèria Mycoplasma fermentans. Primerament, els porus d'una placa d'alúmina mesoporosa són carregats amb un indicador fluorescent (rodamina B). Seguidament, la superfície és funcionalitzada amb una seqüència d'ADN complementaria a una regió altament conservada de la subunitat ribosomal 16S de la bactèria Mycoplasma fermentans. L'impediment estèric generat per les seqüències d'ADN ancorades a l'exterior dels porus impedeix l'alliberament de l'indicador encapsulat. Únicament en presencia d'ADN de la bactèria Mycoplasma fermentans, es produeix l'obertura dels porus permetent la difusió de la càrrega (rodamina B) que és posteriorment mesurada mitjançant fluorescència. En el capítol quatre es dissenya un nanodispositiu capaç de detectar de forma ràpida, sensible i selectiva la bactèria Staphylococcus aureus. Per a la preparació del material sensor, el suport d'alúmina mesoporosa és, primerament, carregat amb l'indicador fluorescent rodamina B. A continuació, els porus del suport són tapats mitjançant l'ancoratge d'un aptàmer que reconeix de forma específica a la bactèria. Solament en presència de Staphylococcus aureus es produeix l'alliberament de l'indicador encapsulat, que és posteriorment mesurat mitjançant espectroscòpia de fluorescència. A més a més, la resposta obtinguda és específica per Staphylococcus aureus. Aquest sistema ha sigut validat amb mostres reals de pacients. En el sisè capítol, es dissenya un nanodispositiu híbrid orgànic-inorgànic consistent en un material d'alúmina mesoporosa cobert amb una seqüència d'ADN específica per a la detecció de l'ADN del fong Pneumocystis jirovecii. En aquest cas, el suport d'alúmina carregat amb l'indicador fluorescent rodamina B és recobert amb una seqüència d'ADN específica per al reconeixement d'aquest fong. En presència de l'organisme, la forquilla hibrida amb l'ADN del fong, resultant en una conformació triplex amb elevada afinitat i estabilitat, que indueix, al mateix temps, el desplaçament d'aquest complex de la superfície. Com a conseqüència d'aquest reconeixement la càrrega és alliberada i quantificada mitjançant espectroscòpia de fluorescència. El sistema ha sigut validat com a mètode diagnòstic mitjançant l'anàlisi de mostres reals de pacients. En el seté capítol, es dissenya un sistema sensor amb la capacitat de detectar gluten de forma ràpida i senzilla en extractes d'aliments processats i no processats. Per a això, un suport d'alúmina mesoporosa es carrega amb indicador fluorescent rodamina B i posteriorment és recobert amb un aptàmer específicament dissenyat per a la detecció de la proteïna gliadina, que constitueix el 50 % del total del clúster d'elements que formen el gluten. L'elevada afinitat i especificitat entre l'aptàmer i la proteïna en qüestió fa que en presència d'aquesta es produesca un desplaçament de la porta molecular que permet la difusió de la càrrega encapsulada i que serà finalment monitoritzada mitjançant espectroscòpia de fluorescència. Finalment, en el capítol vuité es discuteixen de manera conjunta els result / [EN] The PhD thesis hereby presented and entitled "New nanostructured supports with signal amplification features for the detection of molecules and biomolecules of interest", focuses in the design and preparation of new hybrid organic-inorganic materials constituted by molecular gates supported over mesoporous alumina with the aim of developing new sensor probes of potential applications in the fields of diagnosis and food control. In the first chapter, the concepts in which studies and prepared materials are based, are introduced. Next, the second chapter describes the general objectives of this thesis, which will be approached in the following sections. In the third chapter, it is presented in detail the design and optimization process of a nanodevice applied for the detection of Mycoplasma fermentans bacterium. First of all, mesoporous alumina porous films are charged with a fluorescent indicator (rhodamine B). Then, the surface is functionalized with a DNA sequence complementary to a highly conserved region of the 16S ribosomal subunit of the bacterium Mycoplasma fermentans. Steric hindrance generated by DNA sequences on the surface inhibits the release of the encapsulated indicator. Only in the presence of bacterium Mycoplasma fermentans DNA, molecular gates open, allowing payload diffusion to the solution, which is measured by fluorescence spectroscopy. In chapter four, it is carried out the design and optimization of a nanodevice able to detect Staphylococcus aureus bacterium in a fast, sensitive and selective way. For the sensor preparation, alumina mesoporous support is, first, loaded with the rhodamine B fluorescent dye. Then, the mesoporous are blocked through the attachment of an aptamer that recognises specifically this bacterium. Exclusively in the presence of Staphylococcus aureus it is accomplished the release of the encapsulated dye, which is later monitored by fluorescence spectroscopy. The response obtained is specific for Staphylococcus aureus. This system has been validated in real samples. In the sixth chapter, it is detailed the design and optimization process of a hybrid organic-inorganic nanodevice based on a capped mesoporous alumina material for the detection of Pneumocystis jirovecii fungus DNA. In this case, the mesoporous alumina support is loaded with a fluorescent dye and decorated with a specific oligonucleotide sequence designed for the recognition of Pneumocystis fungus. In the presence of the target organism, the fork-like oligonucleotide hybridises with the DNA of the fungus, which results in the adoption of a triplex conformation with high affinity and stability that induces, at the same time, the displacement of this complex from the surface. Consequently, the payload diffused to the solution is quantified through fluorescence spectroscopy. The system has been successfully validated. In the seventh chapter, it was developed a sensor system for gluten detection, in a quick and easy way, in processed and non-processed food extracts. For this, a mesoporous alumina support is loaded with the fluorescent dye rhodamine B, and later was functionalized with an aptamer specifically designed for the detection of gliadin, a protein that constitutes 50 % of average cluster elements that forms gluten. The protein-aptamer high affinity and specificity induce the displacement of the capping aptamer and cargo delivery, which is monitored through fluorescence spectroscopy. Finally, in the eighth chapter, the results obtained in the previous chapters and the potential application of the systems developed as health and food control system are discussed. / We thank the Spanish Government projects MAT2015-64139-C4-1-R, AGL2015-70235-C2-2-R, and TEC2015-71324-R (MINECO/FEDER, UE), the Generalitat Valenciana (project PROMETEOII/2014/047), the Catalan authority (project AGAUR 2014SGR1344), and ICREA under the 2014 ICREA Academia Award for support. This study was supported by the Spanish Government projects RTI2018-100910-B-C41 and SAF2017-82251-R (MCUI/AEI/FEDER, UE), the Generalitat Valenciana (project PROMETEO/2018/024), the Universitat Politècnica de València−Instituto de Investigación Sanitaria La Fe (B02-MIRSA project), CIBER-BBN (NANOPATH and valorization project CANDI-EYE) and co-financed by the EU through the Valencian Community ERDF PO 2014-2020. This research was funded by the Spanish Government, projects RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE) and CTQ2017-84415-R / Pla Blasco, L. (2021). New nanostructured supports with signal amplification features for the detection of molecules and biomolecules of interest [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/166500